Page last updated: 2024-11-01

norfloxacin and Candidiasis, Genital

norfloxacin has been researched along with Candidiasis, Genital in 2 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rocha, RM1
Zanni, PC1
de Souza Bonfim-Mendonça, P1
Gimenes, F1
Alczuk, SS1
Svidzinski, TI1
Consolaro, ME1
Menday, AP1

Trials

1 trial available for norfloxacin and Candidiasis, Genital

ArticleYear
Symptomatic vaginal candidiasis after pivmecillinam and norfloxacin treatment of acute uncomplicated lower urinary tract infection.
    International journal of antimicrobial agents, 2002, Volume: 20, Issue:4

    Topics: Adult; Amdinocillin Pivoxil; Candidiasis, Vulvovaginal; Double-Blind Method; Female; Humans; Middle

2002

Other Studies

1 other study available for norfloxacin and Candidiasis, Genital

ArticleYear
Effect of norfloxacin therapy for acute, uncomplicated lower urinary tract infection on vaginal Candida prevalence.
    International urogynecology journal, 2016, Volume: 27, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Brazil; Candida; Candidiasis, Vulvovaginal;

2016